MedPath

NUTRIZEN PTY LTD

🇦🇺Australia
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

3

TGA:3

Drug Approvals

MYOSITA PLUS (437351)

Product Name
MYOSITA PLUS
Approval Date
Jan 24, 2024
TGA

Renoplus (392190)

Product Name
Renoplus
Approval Date
Jul 13, 2022
TGA

Ribomig (384570)

Product Name
Ribomig
Approval Date
Feb 23, 2022
TGA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.